This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43: 10–17.
Lemmer B . The importance of circadian rhythms on drug response in hypertension and coronary heart disease—from mice and man. Pharmacol Ther 2006; 111: 629–651.
American Society of Hypertension. Recommendations for routine blood pressure measurement by indirect cuff sphygmomanometry. Am J Hypertens 1992; 5: 207–209.
Lemmer B, Portaluppi F . Chronopharmacology of cardiovascular diseases. In: Redfern PH, Lemmer B (eds). Physiology and Pharmacology of Biological Rhythms. Springer: Heidelberg, 1997, pp 251–298.
Sharma AM, Wittchen HU, Kirch W, Pittrow D, Ritz E, Göke B et al. High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens 2004; 22: 479–486.
Stecklings UM, Stoppelhaar M, Sharma AM, Wittchen HU, Krause P, Küpper B et al. HYDRA: possible determinants of unsatisfactory hypertension control in German primary care patients. Blood Press 2004; 13: 80–88.
Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial. Lancet 1998; 351: 1755–1762.
ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC practice guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1751–1762.
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G . Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145–153.
Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U et al. Cardiovascular morbidity and mortality in the Losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995–1003.
Hasford J, Schröder-Bernhardi D, Rottenkolber M, Kostev K, Dietlein G . Persistence with antihypertensive treatments: results of a 3-year follow up cohort study. Eur J Clin Pharmacol 2007; e-pub ahead of print 14 August 2007.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lemmer, B., Middeke, M., Schaaf, B. et al. Prescribing practices and morning blood pressure control: results of a large-scale, primary-care study conducted in Germany. J Hum Hypertens 22, 295–297 (2008). https://doi.org/10.1038/sj.jhh.1002326
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1002326